|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) used for basic net income (loss) per share | |||||
| Adjustments to reconcile net income (loss) to cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Non-cash loss/(gain) on operating lease right-of-use assets | |||||
| Gain on operating lease right-of-use assets | |||||
| Accretion and interest on short-term investments | |||||
| Amortization of right-of-use lease assets | |||||
| Non-cash interest | |||||
| Gain on disposal of property and equipment | |||||
| Gain from sale of priority review voucher | |||||
| Change in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Other receivables | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Accrued taxes | |||||
| Lease liabilities | |||||
| Change in payable to licensor | |||||
| Other current liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sale of priority review voucher, net of transaction costs of $2.6 million | |||||
| Capital expenditures | |||||
| Proceeds from disposal of property and equipment | |||||
| Purchases of short-term investments | |||||
| Proceeds from maturities of short-term investments | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from ATM sales of common stock, net of issuance costs | |||||
| Proceeds from sales of common stock under direct placement offering, net of issuance costs | |||||
| Proceeds from net settlement of restricted share awards | |||||
| Payments related to net settlement of restricted share awards | |||||
| Proceeds from sales of common stock, net of issuance costs | |||||
| Proceeds from underwritten sales of common stock, net of issuance costs | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from issuance of long-term debt | |||||
| Payment of debt issuance costs | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental cash flow information: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Total cash, cash equivalents and restricted cash | |||||
| Supplemental non-cash flow information: | |||||
| Additions (deletions) to right-of-use lease assets in exchange for new or modifications to operating lease liabilities | |||||
| Right-of-use asset obtained in exchange for new operating lease liabilities | |||||
| Derivative and warrant additions associated with loan and security agreement | |||||
| Reclassification of derivative and warrant liability to equity | |||||
| Changes in accrued property and equipment | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
Loading...